1,2-Docosahexanoyl-sn-glycero-3-phosphoserine

Star0

DB11318ApprovedSmall molecule

1,2-Docosahexanoyl-sn-glycero-3-phosphoserine is an ingredient found in a variety of nutritional products.

Formula / weight: C₅₀H₇₄NO₁₀P · 880.097 g/mol (avg)
First approval: United States, 2015
Brand names: EnBrace HR
EnLyte

Resolves to

Compound

UNIIDVY07ILF1WCAS133831-23-9

Clinical / RWD

RxNorm1549115

Structure

InChIKeyRJCZACBLQGCNCW-MCEXTTDUSA-NSMILES

[H]C(CC)=C([H])C\C([H])=C(\[H])C\C([H])=C(\[H])C\C([H])=C(\[H])C\C([H])=C(\[H])C\C([H])=C(\[H])CCC(=O)OC[C@]([H])(COP(O)(=O)OC[C@]([H])(N)C(O)=O)OC(=O)CC\C([H])=C(\[H])C\C([H])=C(\[H])C\C([H])=C(\[H])CC([H])=C([H])C\C([H])=C(\[H])C\C([H])=C(\[H])CC

What you can answer from here — as of August 30, 2026

1Clinical trialPhase, status and sponsor resolved per trial

5Marketed productsAcross 1 country and 2 labellers

Which companies are running trials of 1,2-Docosahexanoyl-sn-glycero-3-phosphoserine, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account